NuVasive, Inc. (NASDAQ:NUVA)

CAPS Rating: 5 out of 5

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

Recs

2
Player Avatar Momentum21 (93.57) Submitted: 10/28/2011 4:02:35 PM : Outperform Start Price: $14.93 NUVA Score: +38.39

bought a few shares for my wife's IRA today at $14.90. I have been watching and haven't liked what I have seen since it traded over $30. Given the sales growth I am willing to gamble on what appears to be crappy management of the expense side. No doubt that there must be some problems but they seem to have enough at stake to eventually get their act together.

Earnings were pretty horrendous...given the past year performance I am banking on the fact that this is capitulation day. : )

Featured Broker Partners


Advertisement